rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2002-6-5
|
pubmed:abstractText |
[corrected] To investigate the mutation at the transmembrane domain of fibroblast growth factor receptor 3 (FGFR3) nucleotide 1138 site for identifying the major pathologic mechanism of achondroplasia (ACH) and to evaluate the efficacy of denaturing gradient gel electrophoresis(DGGE) method for screening the point mutations.
|
pubmed:language |
chi
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1003-9406
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
205-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12048679-Achondroplasia,
pubmed-meshheading:12048679-DNA,
pubmed-meshheading:12048679-DNA Mutational Analysis,
pubmed-meshheading:12048679-Female,
pubmed-meshheading:12048679-Humans,
pubmed-meshheading:12048679-Male,
pubmed-meshheading:12048679-Point Mutation,
pubmed-meshheading:12048679-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:12048679-Polymorphism, Single-Stranded Conformational,
pubmed-meshheading:12048679-Protein-Tyrosine Kinases,
pubmed-meshheading:12048679-Receptor, Fibroblast Growth Factor, Type 3,
pubmed-meshheading:12048679-Receptors, Fibroblast Growth Factor
|
pubmed:year |
2002
|
pubmed:articleTitle |
[Detection of fibroblast growth factor receptor 3 gene mutation at nucleotide 1138 site in congenita achondroplasia patients].
|
pubmed:affiliation |
The Department of Pediatrics of Shanghai Ruijin Hospital, Shanghai Second Medical University, Shanghai, 200025 P. R. China. skz12@citiz.net
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|